首页 > 最新文献

Eye and Vision最新文献

英文 中文
Insights into atypical segmental layer thicknesses and phase retardation in thick corneas using ultrahigh-resolution polarization-sensitive optical coherence tomography. 利用超高分辨率偏振敏感光学相干断层扫描,深入了解厚角膜的非典型节段层厚度和相位延迟。
IF 4.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-07-15 DOI: 10.1186/s40662-024-00391-4
Rahul P Patil, Rohit Shetty, Pooja Khamar, Yash G Patel, Raghav R Narasimhan, Anushree A Bhatkal, Christopher K Hitzenberger, Michael Pircher, Rudy M M R Nuijts, Abhijit Sinha Roy

Background: Accurately assessing corneal structural status is challenging when thickness deviates from the average. Polarization-sensitive optical coherence tomography (PS-OCT) measures tissue-specific polarization changes, providing additional contrast for accurate segmentations and aids in phase retardation (PR) measurements. Previous studies have shown PR's effectiveness in identifying sub-clinical keratoconus (KC) in asymmetric cases. Thus, this study aims to assess PR distribution in thick corneas with and without KC.

Methods: In this retrospective and cross-sectional study, 45 thick corneas from 30 Asian-Indian subjects, categorized into healthy (n = 26) and KC (n = 19) groups were analyzed. All eyes underwent standard clinical evaluations, tomographic assessments, and corneal biomechanics measurements. PR and individual layer thicknesses were measured using custom-designed ultrahigh-resolution PS-OCT. PR en-face maps were generated. Individual layer thicknesses and PR analysis was conducted across multiple zones, extending up to 8-10 mm in diameter. All eyes in the study had not undergone interventions, received topical medications, or had previous corneal disease history.

Results: Significant differences were found in spherical and cylindrical powers, keratometry, pachymetry, and biomechanical indices (all P < 0.01). Thickness profiles from PS-OCT showed significant differences in the 4-8 mm zones only. Bowman's layer thickness significantly differed only in the central 2 mm zone (P = 0.02). The median PR values showed marginal differences in the central 2 mm zone (P = 0.0565). Additionally, there were significant differences observed in the 2-4 mm and 4-6 mm zones (P = 0.0274 and P = 0.0456, respectively). KC eyes exhibited an atypical PR distribution and corneal thinning, while normal eyes maintained a uniform Bowman's layer thickness and PR maps with larger areas of higher PR.

Conclusion: The study revealed distinctive PR distribution in thick corneas among healthy and KC groups. Using an ultrahigh-resolution PS-OCT the significance of Bowman's layer thickness in these groups was also emphasized. The study offered potential improvements in clinical diagnostics by enhancing our understanding of corneal structure and its altered function.

背景:当角膜厚度偏离平均值时,准确评估角膜结构状态是一项挑战。偏振敏感光学相干断层扫描(PS-OCT)可测量组织特异性偏振变化,为准确分割提供额外对比度,并有助于相位延迟(PR)测量。以往的研究表明,PR 能有效识别不对称病例中的亚临床角膜病(KC)。因此,本研究旨在评估 PR 在有 KC 和无 KC 的厚角膜中的分布情况:在这项回顾性横断面研究中,分析了来自 30 名亚洲-印度受试者的 45 个厚角膜,分为健康组(26 人)和 KC 组(19 人)。所有眼睛都接受了标准的临床评估、断层扫描评估和角膜生物力学测量。使用定制的超高分辨率 PS-OCT 对 PR 和单层厚度进行了测量。生成了 PR 全面图。单个角膜层厚度和 PR 分析横跨多个区域,直径可达 8-10 毫米。研究中的所有眼睛都没有接受过干预、局部用药或角膜病史:结果:在球面和柱面力量、角膜测量、角膜厚度和生物力学指数方面都发现了显著差异(均为 P 结论:研究结果表明,PR 在厚角膜中的分布非常明显:该研究揭示了厚角膜 PR 在健康组和 KC 组中的独特分布。利用超高分辨率 PS-OCT 技术,还强调了鲍曼层厚度在这些组别中的重要性。这项研究通过加深我们对角膜结构及其功能变化的了解,为临床诊断提供了潜在的改进方案。
{"title":"Insights into atypical segmental layer thicknesses and phase retardation in thick corneas using ultrahigh-resolution polarization-sensitive optical coherence tomography.","authors":"Rahul P Patil, Rohit Shetty, Pooja Khamar, Yash G Patel, Raghav R Narasimhan, Anushree A Bhatkal, Christopher K Hitzenberger, Michael Pircher, Rudy M M R Nuijts, Abhijit Sinha Roy","doi":"10.1186/s40662-024-00391-4","DOIUrl":"10.1186/s40662-024-00391-4","url":null,"abstract":"<p><strong>Background: </strong>Accurately assessing corneal structural status is challenging when thickness deviates from the average. Polarization-sensitive optical coherence tomography (PS-OCT) measures tissue-specific polarization changes, providing additional contrast for accurate segmentations and aids in phase retardation (PR) measurements. Previous studies have shown PR's effectiveness in identifying sub-clinical keratoconus (KC) in asymmetric cases. Thus, this study aims to assess PR distribution in thick corneas with and without KC.</p><p><strong>Methods: </strong>In this retrospective and cross-sectional study, 45 thick corneas from 30 Asian-Indian subjects, categorized into healthy (n = 26) and KC (n = 19) groups were analyzed. All eyes underwent standard clinical evaluations, tomographic assessments, and corneal biomechanics measurements. PR and individual layer thicknesses were measured using custom-designed ultrahigh-resolution PS-OCT. PR en-face maps were generated. Individual layer thicknesses and PR analysis was conducted across multiple zones, extending up to 8-10 mm in diameter. All eyes in the study had not undergone interventions, received topical medications, or had previous corneal disease history.</p><p><strong>Results: </strong>Significant differences were found in spherical and cylindrical powers, keratometry, pachymetry, and biomechanical indices (all P < 0.01). Thickness profiles from PS-OCT showed significant differences in the 4-8 mm zones only. Bowman's layer thickness significantly differed only in the central 2 mm zone (P = 0.02). The median PR values showed marginal differences in the central 2 mm zone (P = 0.0565). Additionally, there were significant differences observed in the 2-4 mm and 4-6 mm zones (P = 0.0274 and P = 0.0456, respectively). KC eyes exhibited an atypical PR distribution and corneal thinning, while normal eyes maintained a uniform Bowman's layer thickness and PR maps with larger areas of higher PR.</p><p><strong>Conclusion: </strong>The study revealed distinctive PR distribution in thick corneas among healthy and KC groups. Using an ultrahigh-resolution PS-OCT the significance of Bowman's layer thickness in these groups was also emphasized. The study offered potential improvements in clinical diagnostics by enhancing our understanding of corneal structure and its altered function.</p>","PeriodicalId":12194,"journal":{"name":"Eye and Vision","volume":"11 1","pages":"30"},"PeriodicalIF":4.1,"publicationDate":"2024-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11247896/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141616135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Smart decision support system for keratoconus severity staging using corneal curvature and thinnest pachymetry indices. 利用角膜曲率和最薄角膜厚度指数对角膜炎严重程度进行分期的智能决策支持系统。
IF 4.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-07-08 DOI: 10.1186/s40662-024-00394-1
Zahra J Muhsin, Rami Qahwaji, Mo'ath AlShawabkeh, Saif Aldeen AlRyalat, Muawyah Al Bdour, Majid Al-Taee

Background: This study proposes a decision support system created in collaboration with machine learning experts and ophthalmologists for detecting keratoconus (KC) severity. The system employs an ensemble machine model and minimal corneal measurements.

Methods: A clinical dataset is initially obtained from Pentacam corneal tomography imaging devices, which undergoes pre-processing and addresses imbalanced sampling through the application of an oversampling technique for minority classes. Subsequently, a combination of statistical methods, visual analysis, and expert input is employed to identify Pentacam indices most correlated with severity class labels. These selected features are then utilized to develop and validate three distinct machine learning models. The model exhibiting the most effective classification performance is integrated into a real-world web-based application and deployed on a web application server. This deployment facilitates evaluation of the proposed system, incorporating new data and considering relevant human factors related to the user experience.

Results: The performance of the developed system is experimentally evaluated, and the results revealed an overall accuracy of 98.62%, precision of 98.70%, recall of 98.62%, F1-score of 98.66%, and F2-score of 98.64%. The application's deployment also demonstrated precise and smooth end-to-end functionality.

Conclusion: The developed decision support system establishes a robust basis for subsequent assessment by ophthalmologists before potential deployment as a screening tool for keratoconus severity detection in a clinical setting.

背景:本研究提出了一种与机器学习专家和眼科医生合作创建的决策支持系统,用于检测角膜屈光不正(KC)的严重程度。该系统采用了集合机器模型和最小角膜测量方法:方法:首先从 Pentacam 角膜断层成像设备中获取临床数据集,然后对其进行预处理,并通过对少数类别应用超采样技术来解决采样不平衡的问题。随后,综合运用统计方法、视觉分析和专家意见,确定与严重程度类别标签最相关的 Pentacam 指数。然后利用这些选定的特征来开发和验证三种不同的机器学习模型。表现出最有效分类性能的模型被集成到一个真实世界的网络应用程序中,并部署在网络应用程序服务器上。这种部署有助于对所提出的系统进行评估,纳入新的数据,并考虑与用户体验相关的人为因素:对所开发系统的性能进行了实验评估,结果显示系统的总体准确率为 98.62%,精确率为 98.70%,召回率为 98.62%,F1 分数为 98.66%,F2 分数为 98.64%。该应用程序的部署还展示了精确流畅的端到端功能:结论:所开发的决策支持系统为眼科医生进行后续评估奠定了坚实的基础,有望在临床环境中用作角膜病严重程度检测的筛查工具。
{"title":"Smart decision support system for keratoconus severity staging using corneal curvature and thinnest pachymetry indices.","authors":"Zahra J Muhsin, Rami Qahwaji, Mo'ath AlShawabkeh, Saif Aldeen AlRyalat, Muawyah Al Bdour, Majid Al-Taee","doi":"10.1186/s40662-024-00394-1","DOIUrl":"10.1186/s40662-024-00394-1","url":null,"abstract":"<p><strong>Background: </strong>This study proposes a decision support system created in collaboration with machine learning experts and ophthalmologists for detecting keratoconus (KC) severity. The system employs an ensemble machine model and minimal corneal measurements.</p><p><strong>Methods: </strong>A clinical dataset is initially obtained from Pentacam corneal tomography imaging devices, which undergoes pre-processing and addresses imbalanced sampling through the application of an oversampling technique for minority classes. Subsequently, a combination of statistical methods, visual analysis, and expert input is employed to identify Pentacam indices most correlated with severity class labels. These selected features are then utilized to develop and validate three distinct machine learning models. The model exhibiting the most effective classification performance is integrated into a real-world web-based application and deployed on a web application server. This deployment facilitates evaluation of the proposed system, incorporating new data and considering relevant human factors related to the user experience.</p><p><strong>Results: </strong>The performance of the developed system is experimentally evaluated, and the results revealed an overall accuracy of 98.62%, precision of 98.70%, recall of 98.62%, F1-score of 98.66%, and F2-score of 98.64%. The application's deployment also demonstrated precise and smooth end-to-end functionality.</p><p><strong>Conclusion: </strong>The developed decision support system establishes a robust basis for subsequent assessment by ophthalmologists before potential deployment as a screening tool for keratoconus severity detection in a clinical setting.</p>","PeriodicalId":12194,"journal":{"name":"Eye and Vision","volume":"11 1","pages":"28"},"PeriodicalIF":4.1,"publicationDate":"2024-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11229244/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141558440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rotational stability and refractive outcomes of a new hydrophobic acrylic toric intraocular lens. 新型疏水性丙烯酸散光眼内透镜的旋转稳定性和屈光效果。
IF 4.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-07-02 DOI: 10.1186/s40662-024-00393-2
Daniel Schartmüller, Marcus Lisy, Nikolaus Mahnert, Markus Schranz, Victor Danzinger, Luca Schwarzenbacher, Stefan Pieh, Claudette Abela-Formanek, Christina Leydolt, Rupert Menapace

Purpose: To assess rotational stability and refractive outcomes of a new toric hydrophobic acrylic intraocular lens (IOL).

Design: Single-center, prospective, interventional clinical trial.

Methods: A total of 130 eyes of 82 patients with age-related cataract and total corneal astigmatism of greater than 1.0 diopters (D) received a hydrophobic acrylic toric IOL Clareon CNW0T3-9. Baseline measurement for rotational stability evaluation was performed at the end of surgery (EOS), with the patient still supine on the operating table, using non-movable vessels as reference landmarks. Postoperative retroillumination pictures were taken at 1 h, 1 week, 1 month and 4-6 months postoperatively. Subjective manifest refraction was assessed at the 6 months follow-up visit.

Results: Final results were obtained in 126 eyes of 80 patients. Mean absolute rotation from EOS to 6 months was 1.33 ± 2.00 [0.01, 19.80] degrees. Rotational stability values from EOS to 1 h, 1 h to 1 week, 1 week to 1 month and 1 month to 6 months were 0.86 ± 0.82 [0.00, 3.90], 1.06 ± 1.94 [0.00, 19.45], 0.47 ± 0.42 [0.00, 2.03] and 0.38 ± 0.40 [0.00, 2.56] degrees. Mean preoperative corneal astigmatism was 1.78 ± 0.83 [1.00, 4.76] D which changed to a mean postoperative refractive astigmatism of 0.33 ± 0.27 [0.00, 1.25] D at 6 months.

Conclusion: The Clareon toric IOL presented very good rotational stability with a mean absolute rotation below 1.4° from EOS to 6 months. Only two IOLs rotated more than 5° with none of them requiring repositioning surgery. Refractive outcomes were satisfying with a mean residual refractive astigmatism below 0.50 D.

Trial registration: Registered at Clinicaltrials.gov NCT03803852 ; on May 17, 2022.

目的:评估新型散光疏水丙烯酸眼内透镜(IOL)的旋转稳定性和屈光效果:单中心、前瞻性、介入性临床试验:82名患有老年性白内障且角膜散光大于1.0屈光度(D)的患者共130只眼睛接受了疏水性丙烯酸散光人工晶体Clareon CNW0T3-9。旋转稳定性评估的基线测量是在手术结束(EOS)时进行的,当时患者仍仰卧在手术台上,使用不可移动的血管作为参考地标。分别在术后 1 小时、1 周、1 个月和 4-6 个月拍摄术后反照照片。术后 6 个月随访时评估主观屈光度:80名患者的126只眼睛获得了最终结果。从EOS到6个月的平均绝对旋转度为1.33 ± 2.00 [0.01, 19.80]度。从EOS到1小时、1小时到1周、1周到1个月和1个月到6个月的旋转稳定值分别为0.86 ± 0.82 [0.00, 3.90]、1.06 ± 1.94 [0.00, 19.45]、0.47 ± 0.42 [0.00, 2.03]和0.38 ± 0.40 [0.00, 2.56]度。术前平均角膜散光度数为 1.78 ± 0.83 [1.00, 4.76] D,术后 6 个月平均屈光散光度数为 0.33 ± 0.27 [0.00, 1.25] D:Clareon散光人工晶体的旋转稳定性非常好,从EOS到6个月的平均绝对旋转角度低于1.4°。只有两个人工晶体旋转超过 5°,没有一个需要重新定位手术。屈光结果令人满意,平均残余屈光散光低于 0.50 D:试验注册:于 2022 年 5 月 17 日在 Clinicaltrials.gov NCT03803852 注册。
{"title":"Rotational stability and refractive outcomes of a new hydrophobic acrylic toric intraocular lens.","authors":"Daniel Schartmüller, Marcus Lisy, Nikolaus Mahnert, Markus Schranz, Victor Danzinger, Luca Schwarzenbacher, Stefan Pieh, Claudette Abela-Formanek, Christina Leydolt, Rupert Menapace","doi":"10.1186/s40662-024-00393-2","DOIUrl":"10.1186/s40662-024-00393-2","url":null,"abstract":"<p><strong>Purpose: </strong>To assess rotational stability and refractive outcomes of a new toric hydrophobic acrylic intraocular lens (IOL).</p><p><strong>Design: </strong>Single-center, prospective, interventional clinical trial.</p><p><strong>Methods: </strong>A total of 130 eyes of 82 patients with age-related cataract and total corneal astigmatism of greater than 1.0 diopters (D) received a hydrophobic acrylic toric IOL Clareon CNW0T3-9. Baseline measurement for rotational stability evaluation was performed at the end of surgery (EOS), with the patient still supine on the operating table, using non-movable vessels as reference landmarks. Postoperative retroillumination pictures were taken at 1 h, 1 week, 1 month and 4-6 months postoperatively. Subjective manifest refraction was assessed at the 6 months follow-up visit.</p><p><strong>Results: </strong>Final results were obtained in 126 eyes of 80 patients. Mean absolute rotation from EOS to 6 months was 1.33 ± 2.00 [0.01, 19.80] degrees. Rotational stability values from EOS to 1 h, 1 h to 1 week, 1 week to 1 month and 1 month to 6 months were 0.86 ± 0.82 [0.00, 3.90], 1.06 ± 1.94 [0.00, 19.45], 0.47 ± 0.42 [0.00, 2.03] and 0.38 ± 0.40 [0.00, 2.56] degrees. Mean preoperative corneal astigmatism was 1.78 ± 0.83 [1.00, 4.76] D which changed to a mean postoperative refractive astigmatism of 0.33 ± 0.27 [0.00, 1.25] D at 6 months.</p><p><strong>Conclusion: </strong>The Clareon toric IOL presented very good rotational stability with a mean absolute rotation below 1.4° from EOS to 6 months. Only two IOLs rotated more than 5° with none of them requiring repositioning surgery. Refractive outcomes were satisfying with a mean residual refractive astigmatism below 0.50 D.</p><p><strong>Trial registration: </strong>Registered at Clinicaltrials.gov NCT03803852 ; on May 17, 2022.</p>","PeriodicalId":12194,"journal":{"name":"Eye and Vision","volume":"11 1","pages":"25"},"PeriodicalIF":4.1,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11218059/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141476271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Keratectasia severity staging and progression assessment based on the biomechanical E-staging. 基于生物力学 E 分期的角化病严重程度分期和进展评估。
IF 4.1 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-07-01 DOI: 10.1186/s40662-024-00392-3
Elias Flockerzi, Berthold Seitz

Until recently, corneal topography has been the gold standard in detecting keratectasia and monitoring its progression. The recently introduced ABCD tomographic keratoconus staging system focuses on anterior ("A") and posterior ("B") radius of curvature, thinnest corneal thickness ("C"), best-corrected visual acuity with spectacles ("D") and is supplemented with the introduction of the biomechanical E-staging (BEST, "E"). The need for biomechanical staging arose from the fact of altered biomechanical characteristics of keratectasia in comparison to healthy corneas. Ectatic corneas usually exhibit a biomechanical weakening and greater deformation than healthy corneas when exposed to a biomechanical stressor such as a standardized air puff indentation as provided by the Corvis ST® (CST, Oculus, Wetzlar, Germany). The BEST is based on the linear term of the Corvis Biomechanical Index (CBI) and provides a biomechanical keratoconus severity staging and progression assessment within the CST software. This review traces the development of the BEST as an addition to the tomographic ABCD staging system and highlights its strengths and limitations when applied in daily practice for the detection, monitoring and progression assessment in keratectasia.

直到最近,角膜地形图一直是检测角膜异位症和监测其进展的黄金标准。最近推出的 ABCD 层析角膜地形图分期系统侧重于前曲率("A")和后曲率("B")半径、最薄角膜厚度("C")、戴眼镜后的最佳矫正视力("D"),并辅以生物力学 E 分期(BEST,"E")。与健康角膜相比,角膜病变的生物力学特征发生了改变,因此需要进行生物力学分期。与健康角膜相比,外生性角膜在受到生物力学应力(如 Corvis ST® (CST, Oculus, Wetzlar, Germany) 提供的标准化气囊压痕)时,通常会表现出生物力学减弱和更大的变形。BEST 以 Corvis 生物力学指数 (CBI) 的线性项为基础,在 CST 软件中提供了生物力学角膜病严重程度分期和进展评估。本综述回顾了 BEST 作为断层扫描 ABCD 分期系统的补充的发展历程,并强调了其在日常应用于角膜病的检测、监测和进展评估时的优势和局限性。
{"title":"Keratectasia severity staging and progression assessment based on the biomechanical E-staging.","authors":"Elias Flockerzi, Berthold Seitz","doi":"10.1186/s40662-024-00392-3","DOIUrl":"10.1186/s40662-024-00392-3","url":null,"abstract":"<p><p>Until recently, corneal topography has been the gold standard in detecting keratectasia and monitoring its progression. The recently introduced ABCD tomographic keratoconus staging system focuses on anterior (\"A\") and posterior (\"B\") radius of curvature, thinnest corneal thickness (\"C\"), best-corrected visual acuity with spectacles (\"D\") and is supplemented with the introduction of the biomechanical E-staging (BEST, \"E\"). The need for biomechanical staging arose from the fact of altered biomechanical characteristics of keratectasia in comparison to healthy corneas. Ectatic corneas usually exhibit a biomechanical weakening and greater deformation than healthy corneas when exposed to a biomechanical stressor such as a standardized air puff indentation as provided by the Corvis ST® (CST, Oculus, Wetzlar, Germany). The BEST is based on the linear term of the Corvis Biomechanical Index (CBI) and provides a biomechanical keratoconus severity staging and progression assessment within the CST software. This review traces the development of the BEST as an addition to the tomographic ABCD staging system and highlights its strengths and limitations when applied in daily practice for the detection, monitoring and progression assessment in keratectasia.</p>","PeriodicalId":12194,"journal":{"name":"Eye and Vision","volume":"11 1","pages":"24"},"PeriodicalIF":4.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11215830/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141467274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel artificial intelligence algorithms for diabetic retinopathy and diabetic macular edema. 针对糖尿病视网膜病变和糖尿病黄斑水肿的新型人工智能算法。
IF 4.2 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-06-17 DOI: 10.1186/s40662-024-00389-y
Jie Yao, Joshua Lim, Gilbert Yong San Lim, Jasmine Chiat Ling Ong, Yuhe Ke, Ting Fang Tan, Tien-En Tan, Stela Vujosevic, Daniel Shu Wei Ting

Background: Diabetic retinopathy (DR) and diabetic macular edema (DME) are major causes of visual impairment that challenge global vision health. New strategies are needed to tackle these growing global health problems, and the integration of artificial intelligence (AI) into ophthalmology has the potential to revolutionize DR and DME management to meet these challenges.

Main text: This review discusses the latest AI-driven methodologies in the context of DR and DME in terms of disease identification, patient-specific disease profiling, and short-term and long-term management. This includes current screening and diagnostic systems and their real-world implementation, lesion detection and analysis, disease progression prediction, and treatment response models. It also highlights the technical advancements that have been made in these areas. Despite these advancements, there are obstacles to the widespread adoption of these technologies in clinical settings, including regulatory and privacy concerns, the need for extensive validation, and integration with existing healthcare systems. We also explore the disparity between the potential of AI models and their actual effectiveness in real-world applications.

Conclusion: AI has the potential to revolutionize the management of DR and DME, offering more efficient and precise tools for healthcare professionals. However, overcoming challenges in deployment, regulatory compliance, and patient privacy is essential for these technologies to realize their full potential. Future research should aim to bridge the gap between technological innovation and clinical application, ensuring AI tools integrate seamlessly into healthcare workflows to enhance patient outcomes.

背景:糖尿病视网膜病变(DR)和糖尿病黄斑水肿(DME)是视力损伤的主要原因,对全球视力健康构成挑战。要解决这些日益严重的全球健康问题,需要采取新的策略,而将人工智能(AI)融入眼科,有可能彻底改变 DR 和 DME 的管理,从而应对这些挑战:这篇综述从疾病识别、特定患者的疾病特征描述以及短期和长期管理等方面,讨论了针对 DR 和 DME 的最新人工智能驱动方法。其中包括当前的筛查和诊断系统及其在现实世界中的应用、病变检测和分析、疾病进展预测以及治疗反应模型。报告还重点介绍了这些领域取得的技术进步。尽管取得了这些进步,但在临床环境中广泛采用这些技术仍存在障碍,包括监管和隐私问题、广泛验证的需要以及与现有医疗系统的整合。我们还探讨了人工智能模型的潜力与实际应用效果之间的差距:人工智能有可能彻底改变 DR 和 DME 的管理,为医疗保健专业人员提供更高效、更精确的工具。然而,要充分发挥这些技术的潜力,克服部署、合规性和患者隐私方面的挑战至关重要。未来的研究应致力于弥合技术创新与临床应用之间的差距,确保人工智能工具与医疗保健工作流程无缝整合,从而提高患者的治疗效果。
{"title":"Novel artificial intelligence algorithms for diabetic retinopathy and diabetic macular edema.","authors":"Jie Yao, Joshua Lim, Gilbert Yong San Lim, Jasmine Chiat Ling Ong, Yuhe Ke, Ting Fang Tan, Tien-En Tan, Stela Vujosevic, Daniel Shu Wei Ting","doi":"10.1186/s40662-024-00389-y","DOIUrl":"10.1186/s40662-024-00389-y","url":null,"abstract":"<p><strong>Background: </strong>Diabetic retinopathy (DR) and diabetic macular edema (DME) are major causes of visual impairment that challenge global vision health. New strategies are needed to tackle these growing global health problems, and the integration of artificial intelligence (AI) into ophthalmology has the potential to revolutionize DR and DME management to meet these challenges.</p><p><strong>Main text: </strong>This review discusses the latest AI-driven methodologies in the context of DR and DME in terms of disease identification, patient-specific disease profiling, and short-term and long-term management. This includes current screening and diagnostic systems and their real-world implementation, lesion detection and analysis, disease progression prediction, and treatment response models. It also highlights the technical advancements that have been made in these areas. Despite these advancements, there are obstacles to the widespread adoption of these technologies in clinical settings, including regulatory and privacy concerns, the need for extensive validation, and integration with existing healthcare systems. We also explore the disparity between the potential of AI models and their actual effectiveness in real-world applications.</p><p><strong>Conclusion: </strong>AI has the potential to revolutionize the management of DR and DME, offering more efficient and precise tools for healthcare professionals. However, overcoming challenges in deployment, regulatory compliance, and patient privacy is essential for these technologies to realize their full potential. Future research should aim to bridge the gap between technological innovation and clinical application, ensuring AI tools integrate seamlessly into healthcare workflows to enhance patient outcomes.</p>","PeriodicalId":12194,"journal":{"name":"Eye and Vision","volume":"11 1","pages":"23"},"PeriodicalIF":4.2,"publicationDate":"2024-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11181581/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141330701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preliminary study of cyclosporine A/Lifitegrast subconjunctival sustained-release drug membrane in the treatment of dry eyes. 环孢素 A/Lifitegrast 结膜下缓释药物膜治疗干眼症的初步研究。
IF 4.2 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-06-13 DOI: 10.1186/s40662-024-00390-5
Jie Yang, Miao Chen, Fangyuan Wu, Jingjing Zuo, Huixiang Ma

Background: Dry eyes can cause discomfort. To treat dry eye disease, cyclosporine A (CsA) and Lifitegrast are two eye drugs approved by the U.S. Food and Drug Administration (FDA). However, frequent use of eye drops can be challenging and lead to poor compliance, especially in elderly patients. Therefore, this study aimed to develop a drug sustained-release vector and explore its therapeutic effect in animal models of dry eye.

Methods: Firstly, drug membranes loaded with both CsA and Lifitegrast using a carrier called poly(lactate-co-ε-caprolactone) (P(LLA-CL)) were prepared and evaluated for their physicochemical properties, release behavior in vitro, and safety in vivo. Next, a rabbit dry eye model using a 0.1% benzalkonium chloride (BAC) solution was developed and treated by drug-loaded micro membranes. We observed and recorded conjunctival hyperemia, corneal staining, corneal edema, corneal neovascularization, conjunctival goblet cells and hematoxylin and eosin (H&E) staining. Finally, we detected the MUC5AC and MMP-9 by immunofluorescence staining and enzyme-linked immunosorbent assay (ELISA).

Results: The composite film released both CsA and Lifitegrast for at least one month. Compared to the blank membrane group, conjunctival hyperemia, corneal fluorescein staining, corneal edema, corneal neovascularization and conjunctival goblet cells recovered faster in the drug membrane group, and the difference was statistically significant. At the molecular level, the drug membrane group showed an increase in mucin density and a significant anti-inflammatory effect.

Conclusions: The implantation of CsA/Lifitegrast loaded P(LLA-CL) membrane under the subconjunctival of the rabbit eye is safe. The study suggests that this subconjunctival administration could be developed into a minimally invasive delivery system to help patients with dry eye disease who require multiple daily eyedrops but have poor compliance.

背景介绍干眼症会引起不适。环孢素 A (CsA) 和 Lifitegrast 是美国食品和药物管理局 (FDA) 批准用于治疗干眼症的两种眼药。然而,频繁使用眼药水可能具有挑战性,并导致依从性差,尤其是老年患者。因此,本研究旨在开发一种药物缓释载体,并探索其在干眼症动物模型中的治疗效果:方法:首先,使用一种名为聚(乳酸-co-ε-己内酯)(P(LLA-CL))的载体制备了负载有 CsA 和 Lifitegrast 的药物膜,并对其理化性质、体外释放行为和体内安全性进行了评估。接着,我们使用 0.1% 苯扎氯铵(BAC)溶液建立了兔子干眼症模型,并用载药微膜进行了处理。我们观察并记录了结膜充血、角膜染色、角膜水肿、角膜新生血管、结膜小胶质细胞以及苏木精和伊红(H&E)染色。最后,我们通过免疫荧光染色和酶联免疫吸附试验(ELISA)检测了MUC5AC和MMP-9:结果:复合膜可释放 CsA 和 Lifitegrast 至少一个月。与空白膜组相比,药物膜组的结膜充血、角膜荧光素染色、角膜水肿、角膜新生血管和结膜上皮细胞恢复更快,差异有统计学意义。在分子水平上,药膜组的粘蛋白密度增加,抗炎效果显著:结论:CsA/Lifitegrast负载的P(LLA-CL)膜植入兔眼结膜下是安全的。该研究表明,这种结膜下给药方式可发展成一种微创给药系统,以帮助每天需要多次滴眼但依从性差的干眼症患者。
{"title":"Preliminary study of cyclosporine A/Lifitegrast subconjunctival sustained-release drug membrane in the treatment of dry eyes.","authors":"Jie Yang, Miao Chen, Fangyuan Wu, Jingjing Zuo, Huixiang Ma","doi":"10.1186/s40662-024-00390-5","DOIUrl":"10.1186/s40662-024-00390-5","url":null,"abstract":"<p><strong>Background: </strong>Dry eyes can cause discomfort. To treat dry eye disease, cyclosporine A (CsA) and Lifitegrast are two eye drugs approved by the U.S. Food and Drug Administration (FDA). However, frequent use of eye drops can be challenging and lead to poor compliance, especially in elderly patients. Therefore, this study aimed to develop a drug sustained-release vector and explore its therapeutic effect in animal models of dry eye.</p><p><strong>Methods: </strong>Firstly, drug membranes loaded with both CsA and Lifitegrast using a carrier called poly(lactate-co-ε-caprolactone) (P(LLA-CL)) were prepared and evaluated for their physicochemical properties, release behavior in vitro, and safety in vivo. Next, a rabbit dry eye model using a 0.1% benzalkonium chloride (BAC) solution was developed and treated by drug-loaded micro membranes. We observed and recorded conjunctival hyperemia, corneal staining, corneal edema, corneal neovascularization, conjunctival goblet cells and hematoxylin and eosin (H&E) staining. Finally, we detected the MUC5AC and MMP-9 by immunofluorescence staining and enzyme-linked immunosorbent assay (ELISA).</p><p><strong>Results: </strong>The composite film released both CsA and Lifitegrast for at least one month. Compared to the blank membrane group, conjunctival hyperemia, corneal fluorescein staining, corneal edema, corneal neovascularization and conjunctival goblet cells recovered faster in the drug membrane group, and the difference was statistically significant. At the molecular level, the drug membrane group showed an increase in mucin density and a significant anti-inflammatory effect.</p><p><strong>Conclusions: </strong>The implantation of CsA/Lifitegrast loaded P(LLA-CL) membrane under the subconjunctival of the rabbit eye is safe. The study suggests that this subconjunctival administration could be developed into a minimally invasive delivery system to help patients with dry eye disease who require multiple daily eyedrops but have poor compliance.</p>","PeriodicalId":12194,"journal":{"name":"Eye and Vision","volume":"11 1","pages":"22"},"PeriodicalIF":4.2,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11170774/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141316918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of manual and artificial intelligence-automated choroidal thickness segmentation of optical coherence tomography imaging in myopic adults. 近视成人光学相干断层成像的脉络膜厚度人工分割与人工智能自动分割的比较。
IF 4.2 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-06-03 DOI: 10.1186/s40662-024-00385-2
Zhi Wei Lim, Jonathan Li, Damon Wong, Joey Chung, Angeline Toh, Jia Ling Lee, Crystal Lam, Maithily Balakrishnan, Audrey Chia, Jacqueline Chua, Michael Girard, Quan V Hoang, Rachel Chong, Chee Wai Wong, Seang Mei Saw, Leopold Schmetterer, Noel Brennan, Marcus Ang

Background: Myopia affects 1.4 billion individuals worldwide. Notably, there is increasing evidence that choroidal thickness plays an important role in myopia and risk of developing myopia-related conditions. With the advancements in artificial intelligence (AI), choroidal thickness segmentation can now be automated, offering inherent advantages such as better repeatability, reduced grader variability, and less reliance for manpower. Hence, we aimed to evaluate the agreement between AI-automated and manual segmented measurements of subfoveal choroidal thickness (SFCT) using two swept-source optical coherence tomography (OCT) systems.

Methods: Subjects aged ≥ 16 years, with myopia of ≥ 0.50 diopters in both eyes, were recruited from the Prospective Myopia Cohort Study in Singapore (PROMYSE). OCT scans were acquired using Triton DRI-OCT and PLEX Elite 9000. OCT images were segmented both automatically with an established SA-Net architecture and manually using a standard technique with adjudication by two independent graders. SFCT was subsequently determined based on the segmentation. The Bland-Altman plot and intraclass correlation coefficient (ICC) were used to evaluate the agreement.

Results: A total of 229 subjects (456 eyes) with mean [± standard deviation (SD)] age of 34.1 (10.4) years were included. The overall SFCT (mean ± SD) based on manual segmentation was 216.9 ± 82.7 µm with Triton DRI-OCT and 239.3 ± 84.3 µm with PLEX Elite 9000. ICC values demonstrated excellent agreement between AI-automated and manual segmented SFCT measurements (PLEX Elite 9000: ICC = 0.937, 95% CI: 0.922 to 0.949, P < 0.001; Triton DRI-OCT: ICC = 0.887, 95% CI: 0.608 to 0.950, P < 0.001). For PLEX Elite 9000, manual segmented measurements were generally thicker when compared to AI-automated segmented measurements, with a fixed bias of 6.3 µm (95% CI: 3.8 to 8.9, P < 0.001) and proportional bias of 0.120 (P < 0.001). On the other hand, manual segmented measurements were comparatively thinner than AI-automated segmented measurements for Triton DRI-OCT, with a fixed bias of - 26.7 µm (95% CI: - 29.7 to - 23.7, P < 0.001) and proportional bias of - 0.090 (P < 0.001).

Conclusion: We observed an excellent agreement in choroidal segmentation measurements when comparing manual with AI-automated techniques, using images from two SS-OCT systems. Given its edge over manual segmentation, automated segmentation may potentially emerge as the primary method of choroidal thickness measurement in the future.

背景:全世界有 14 亿人患有近视。值得注意的是,越来越多的证据表明脉络膜厚度在近视和近视相关疾病的发病风险中起着重要作用。随着人工智能(AI)的发展,脉络膜厚度的分割现在可以实现自动化,从而提供了固有的优势,如更好的可重复性、降低分级机的可变性以及减少对人力的依赖。因此,我们旨在评估使用两种扫源光学相干断层扫描(OCT)系统对脉络膜下厚度(SFCT)进行人工智能自动分段测量与手动分段测量之间的一致性:从新加坡前瞻性近视队列研究(PROMYSE)中招募年龄≥ 16 岁、双眼近视度数≥ 0.50 度的受试者。使用 Triton DRI-OCT 和 PLEX Elite 9000 采集了 OCT 扫描图像。OCT 图像采用已建立的 SA-Net 架构自动分割,也采用标准技术手动分割,并由两名独立分级人员进行裁决。随后根据分割结果确定 SFCT。布兰德-阿尔特曼图和类内相关系数(ICC)用于评估一致性:共纳入 229 名受试者(456 只眼),平均[± 标准差 (SD)]年龄为 34.1 (10.4)岁。Triton DRI-OCT 和 PLEX Elite 9000 根据手动分割得出的总体 SFCT(平均值±标准差)分别为 216.9 ± 82.7 µm 和 239.3 ± 84.3 µm。ICC 值显示,AI 自动和手动分割 SFCT 测量结果之间的一致性极佳(PLEX Elite 9000:ICC = 0.937,95% CI:0.922 至 0.949,P 结论:AI 自动和手动分割 SFCT 测量结果之间的一致性极佳(PLEX Elite 9000:ICC = 0.937,95% CI:0.922 至 0.949,P 结论):我们使用两套 SS-OCT 系统的图像,比较了人工和 AI 自动技术,发现两者在脉络膜分割测量方面的一致性非常好。与手动分割相比,自动分割技术更具优势,有可能成为未来测量脉络膜厚度的主要方法。
{"title":"Comparison of manual and artificial intelligence-automated choroidal thickness segmentation of optical coherence tomography imaging in myopic adults.","authors":"Zhi Wei Lim, Jonathan Li, Damon Wong, Joey Chung, Angeline Toh, Jia Ling Lee, Crystal Lam, Maithily Balakrishnan, Audrey Chia, Jacqueline Chua, Michael Girard, Quan V Hoang, Rachel Chong, Chee Wai Wong, Seang Mei Saw, Leopold Schmetterer, Noel Brennan, Marcus Ang","doi":"10.1186/s40662-024-00385-2","DOIUrl":"10.1186/s40662-024-00385-2","url":null,"abstract":"<p><strong>Background: </strong>Myopia affects 1.4 billion individuals worldwide. Notably, there is increasing evidence that choroidal thickness plays an important role in myopia and risk of developing myopia-related conditions. With the advancements in artificial intelligence (AI), choroidal thickness segmentation can now be automated, offering inherent advantages such as better repeatability, reduced grader variability, and less reliance for manpower. Hence, we aimed to evaluate the agreement between AI-automated and manual segmented measurements of subfoveal choroidal thickness (SFCT) using two swept-source optical coherence tomography (OCT) systems.</p><p><strong>Methods: </strong>Subjects aged ≥ 16 years, with myopia of ≥ 0.50 diopters in both eyes, were recruited from the Prospective Myopia Cohort Study in Singapore (PROMYSE). OCT scans were acquired using Triton DRI-OCT and PLEX Elite 9000. OCT images were segmented both automatically with an established SA-Net architecture and manually using a standard technique with adjudication by two independent graders. SFCT was subsequently determined based on the segmentation. The Bland-Altman plot and intraclass correlation coefficient (ICC) were used to evaluate the agreement.</p><p><strong>Results: </strong>A total of 229 subjects (456 eyes) with mean [± standard deviation (SD)] age of 34.1 (10.4) years were included. The overall SFCT (mean ± SD) based on manual segmentation was 216.9 ± 82.7 µm with Triton DRI-OCT and 239.3 ± 84.3 µm with PLEX Elite 9000. ICC values demonstrated excellent agreement between AI-automated and manual segmented SFCT measurements (PLEX Elite 9000: ICC = 0.937, 95% CI: 0.922 to 0.949, P < 0.001; Triton DRI-OCT: ICC = 0.887, 95% CI: 0.608 to 0.950, P < 0.001). For PLEX Elite 9000, manual segmented measurements were generally thicker when compared to AI-automated segmented measurements, with a fixed bias of 6.3 µm (95% CI: 3.8 to 8.9, P < 0.001) and proportional bias of 0.120 (P < 0.001). On the other hand, manual segmented measurements were comparatively thinner than AI-automated segmented measurements for Triton DRI-OCT, with a fixed bias of - 26.7 µm (95% CI: - 29.7 to - 23.7, P < 0.001) and proportional bias of - 0.090 (P < 0.001).</p><p><strong>Conclusion: </strong>We observed an excellent agreement in choroidal segmentation measurements when comparing manual with AI-automated techniques, using images from two SS-OCT systems. Given its edge over manual segmentation, automated segmentation may potentially emerge as the primary method of choroidal thickness measurement in the future.</p>","PeriodicalId":12194,"journal":{"name":"Eye and Vision","volume":"11 1","pages":"21"},"PeriodicalIF":4.2,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11145894/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141237149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corneal injury repair and the potential involvement of ZEB1. 角膜损伤修复和 ZEB1 的潜在参与。
IF 4.2 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-06-01 DOI: 10.1186/s40662-024-00387-0
Lin Jin, Lijun Zhang, Chunxiao Yan, Mengxin Liu, Douglas C Dean, Yongqing Liu

The cornea, consisting of three cellular and two non-cellular layers, is the outermost part of the eyeball and frequently injured by external physical, chemical, and microbial insults. The epithelial-to-mesenchymal transition (EMT) plays a crucial role in the repair of corneal injuries. Zinc finger E-box binding homeobox 1 (ZEB1), an important transcription factor involved in EMT, is expressed in the corneal tissues. It regulates cell activities like migration, transformation, and proliferation, and thereby affects tissue inflammation, fibrosis, tumor metastasis, and necrosis by mediating various major signaling pathways, including transforming growth factor (TGF)-β. Dysfunction of ZEB1 would impair corneal tissue repair leading to epithelial healing delay, interstitial fibrosis, neovascularization, and squamous cell metaplasia. Understanding the mechanism underlying ZEB1 regulation of corneal injury repair will help us to formulate a therapeutic approach to enhance corneal injury repair.

角膜由三个细胞层和两个非细胞层组成,是眼球的最外层,经常受到外部物理、化学和微生物的损伤。上皮细胞向间质转化(EMT)在角膜损伤的修复中起着至关重要的作用。锌指E盒结合同源框1(ZEB1)是参与EMT的一个重要转录因子,在角膜组织中表达。它通过介导包括转化生长因子(TGF)-β在内的各种主要信号通路,调节细胞的迁移、转化和增殖等活动,从而影响组织炎症、纤维化、肿瘤转移和坏死。ZEB1 的功能障碍会损害角膜组织的修复,导致上皮愈合延迟、间质纤维化、新生血管形成和鳞状细胞增生。了解 ZEB1 对角膜损伤修复的调控机制将有助于我们制定加强角膜损伤修复的治疗方法。
{"title":"Corneal injury repair and the potential involvement of ZEB1.","authors":"Lin Jin, Lijun Zhang, Chunxiao Yan, Mengxin Liu, Douglas C Dean, Yongqing Liu","doi":"10.1186/s40662-024-00387-0","DOIUrl":"10.1186/s40662-024-00387-0","url":null,"abstract":"<p><p>The cornea, consisting of three cellular and two non-cellular layers, is the outermost part of the eyeball and frequently injured by external physical, chemical, and microbial insults. The epithelial-to-mesenchymal transition (EMT) plays a crucial role in the repair of corneal injuries. Zinc finger E-box binding homeobox 1 (ZEB1), an important transcription factor involved in EMT, is expressed in the corneal tissues. It regulates cell activities like migration, transformation, and proliferation, and thereby affects tissue inflammation, fibrosis, tumor metastasis, and necrosis by mediating various major signaling pathways, including transforming growth factor (TGF)-β. Dysfunction of ZEB1 would impair corneal tissue repair leading to epithelial healing delay, interstitial fibrosis, neovascularization, and squamous cell metaplasia. Understanding the mechanism underlying ZEB1 regulation of corneal injury repair will help us to formulate a therapeutic approach to enhance corneal injury repair.</p>","PeriodicalId":12194,"journal":{"name":"Eye and Vision","volume":"11 1","pages":"20"},"PeriodicalIF":4.2,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11143703/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141186240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of RCI001 as a therapeutic candidate of dry eye disease in a modified mixed dry eye model. RCI001 作为干眼症候选疗法在改良混合干眼症模型中的疗效。
IF 4.2 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-06-01 DOI: 10.1186/s40662-024-00388-z
Young-Ho Jung, Young Ah Ku, Jayoon Moon, Seunghoon Kim, Jin Suk Ryu, Chang Ho Yoon, Myung Hee Chung, Yong Ho Kim, Mee Kum Kim, Dong Hyun Kim

Background: To evaluate the therapeutic effects of topical RCI001 (RCI) and compare its efficacy with that of 1% prednisolone acetate (PDE) and 5% Lifitegrast in a modified mixed dry eye disease (DED) model.

Methods: The environmental DED model was induced in BALB/c mice in a dry chamber with scopolamine. The eyes of the mice were treated topically with phosphate buffered saline (PBS), PDE, Lifitegrast or RCI twice daily for 1 week. Ocular surface staining (OSS), tear secretion, inflammatory cytokines in the ocular surface and lacrimal gland, and immunofluorescence staining in the conjunctiva and cornea(CC) were assessed.

Results: The RCI group demonstrated better improvement of OSS and tear secretion than the PBS group (OSS, PBS: 13.0 ± 1.6, RCI: 9.4 ± 3.0; tear secretion, PBS: 5.0 ± 0.4 mm, RCI: 7.0 ± 0.3 mm, each P < 0.001) and better clinical efficacy than PDE and Lifitegrast groups on Day 7 (improvement rate of OSS, RCI: 32.45%, Lifitegrast: 13.13%, PDE: 12.25%). The RCI group resulted in significantly lower expression of oxidative stress markers in the CC than the PBS group (4-HNE, NOX2, and NOX4 in the conjunctiva; NOX2 in the cornea, each P < 0.05). However, the PDE and Lifitegrast groups did not show significant differences compared with the PBS group. There were no significant differences of inflammatory cytokines in the ocular surface and lacrimal gland between all groups.

Conclusion: Topical RCI001 showed excellent therapeutic effects in environmental DED models by stimulating tear secretion, modulating oxidative stress and improving corneal epithelial healing compared to 1% PDE and 5% Lifitegrast.

背景:目的:评估外用 RCI001(RCI)的治疗效果,并比较其与 1%醋酸泼尼松龙(PDE)和 5%利福瑞(Lifitegrast)在改良的混合性干眼症(DED)模型中的疗效:方法:在干燥箱中用东莨菪碱诱导 BALB/c 小鼠建立环境 DED 模型。用磷酸盐缓冲盐水(PBS)、PDE、Lifitegrast 或 RCI 对小鼠的眼睛进行局部治疗,每天两次,持续一周。对小鼠眼表染色(OSS)、泪液分泌、眼表和泪腺中的炎性细胞因子以及结膜和角膜(CC)的免疫荧光染色进行了评估:结果:与 PBS 组相比,RCI 组在 OSS 和泪液分泌方面有更好的改善(OSS,PBS:13.0 ± 1.6;RCI:13.0 ± 1.6;PBS:13.0 ± 1.6):OSS,PBS:13.0 ± 1.6,RCI:9.4 ± 3.0;泪液分泌,PBS:5.0 ± 0.4 mm):泪液分泌,PBS:5.0 ± 0.4 mm,RCI:7.0 ± 0.3 mm,各 P 结论:与 1% PDE 和 5% Lifitegrast 相比,外用 RCI001 通过刺激泪液分泌、调节氧化应激和改善角膜上皮愈合,在环境 DED 模型中显示出卓越的治疗效果。
{"title":"Efficacy of RCI001 as a therapeutic candidate of dry eye disease in a modified mixed dry eye model.","authors":"Young-Ho Jung, Young Ah Ku, Jayoon Moon, Seunghoon Kim, Jin Suk Ryu, Chang Ho Yoon, Myung Hee Chung, Yong Ho Kim, Mee Kum Kim, Dong Hyun Kim","doi":"10.1186/s40662-024-00388-z","DOIUrl":"10.1186/s40662-024-00388-z","url":null,"abstract":"<p><strong>Background: </strong>To evaluate the therapeutic effects of topical RCI001 (RCI) and compare its efficacy with that of 1% prednisolone acetate (PDE) and 5% Lifitegrast in a modified mixed dry eye disease (DED) model.</p><p><strong>Methods: </strong>The environmental DED model was induced in BALB/c mice in a dry chamber with scopolamine. The eyes of the mice were treated topically with phosphate buffered saline (PBS), PDE, Lifitegrast or RCI twice daily for 1 week. Ocular surface staining (OSS), tear secretion, inflammatory cytokines in the ocular surface and lacrimal gland, and immunofluorescence staining in the conjunctiva and cornea(CC) were assessed.</p><p><strong>Results: </strong>The RCI group demonstrated better improvement of OSS and tear secretion than the PBS group (OSS, PBS: 13.0 ± 1.6, RCI: 9.4 ± 3.0; tear secretion, PBS: 5.0 ± 0.4 mm, RCI: 7.0 ± 0.3 mm, each P < 0.001) and better clinical efficacy than PDE and Lifitegrast groups on Day 7 (improvement rate of OSS, RCI: 32.45%, Lifitegrast: 13.13%, PDE: 12.25%). The RCI group resulted in significantly lower expression of oxidative stress markers in the CC than the PBS group (4-HNE, NOX2, and NOX4 in the conjunctiva; NOX2 in the cornea, each P < 0.05). However, the PDE and Lifitegrast groups did not show significant differences compared with the PBS group. There were no significant differences of inflammatory cytokines in the ocular surface and lacrimal gland between all groups.</p><p><strong>Conclusion: </strong>Topical RCI001 showed excellent therapeutic effects in environmental DED models by stimulating tear secretion, modulating oxidative stress and improving corneal epithelial healing compared to 1% PDE and 5% Lifitegrast.</p>","PeriodicalId":12194,"journal":{"name":"Eye and Vision","volume":"11 1","pages":"19"},"PeriodicalIF":4.2,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11143567/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141186241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multi-modal imaging for the detection of early keratoconus: a narrative review. 用于检测早期角膜炎的多模态成像:综述。
IF 4.2 1区 医学 Q1 OPHTHALMOLOGY Pub Date : 2024-05-11 DOI: 10.1186/s40662-024-00386-1
Muawyah Al Bdour, Hashem M Sabbagh, Hisham M Jammal

Keratoconus is a common progressive corneal disorder that can be associated with significant ocular morbidity. Various corneal imaging techniques have been used for the diagnosis of established cases. However, in the early stages of the disease, which include subclinical keratoconus and forme fruste keratoconus, detection of such cases can be challenging. The importance of detecting such cases is very important because early intervention can halt disease progression, improve visual outcomes and prevent postrefractive surgery ectasia associated with performing corneal refractive procedures in such patients. This narrative review aimed to examine several established and evolving imaging techniques for the detection of early cases of keratoconus. The utilization of combinations of these techniques may further increase their diagnostic ability.

角膜炎是一种常见的进行性角膜病变,可导致严重的眼部疾病。各种角膜成像技术已被用于诊断已确诊的病例。然而,在该疾病的早期阶段,包括亚临床角膜病和Forme fruste角膜病,检测这类病例可能具有挑战性。发现这类病例非常重要,因为早期干预可以阻止疾病的发展,改善视觉效果,并防止为这类患者实施角膜屈光手术时引起的屈光手术后异位。本综述旨在研究几种用于检测早期角膜炎病例的成熟和不断发展的成像技术。这些技术的组合使用可进一步提高诊断能力。
{"title":"Multi-modal imaging for the detection of early keratoconus: a narrative review.","authors":"Muawyah Al Bdour, Hashem M Sabbagh, Hisham M Jammal","doi":"10.1186/s40662-024-00386-1","DOIUrl":"10.1186/s40662-024-00386-1","url":null,"abstract":"<p><p>Keratoconus is a common progressive corneal disorder that can be associated with significant ocular morbidity. Various corneal imaging techniques have been used for the diagnosis of established cases. However, in the early stages of the disease, which include subclinical keratoconus and forme fruste keratoconus, detection of such cases can be challenging. The importance of detecting such cases is very important because early intervention can halt disease progression, improve visual outcomes and prevent postrefractive surgery ectasia associated with performing corneal refractive procedures in such patients. This narrative review aimed to examine several established and evolving imaging techniques for the detection of early cases of keratoconus. The utilization of combinations of these techniques may further increase their diagnostic ability.</p>","PeriodicalId":12194,"journal":{"name":"Eye and Vision","volume":"11 1","pages":"18"},"PeriodicalIF":4.2,"publicationDate":"2024-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11088107/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140904322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Eye and Vision
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1